BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bryl E. B cells as target for immunotherapy in rheumatic diseases - current status. Immunol Lett 2021;236:12-9. [PMID: 34077805 DOI: 10.1016/j.imlet.2021.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bazzi SA, Maguire C, Holay N, Geltman J, Hurley K, DiPasquale C, Abigania M, Olson E, Ehrlich LIR, Triplett TA, Melamed E. Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy. Mult Scler Relat Disord 2022;68:104195. [PMID: 36223705 DOI: 10.1016/j.msard.2022.104195] [Reference Citation Analysis]
2 Qin Y, Cai ML, Jin HZ, Huang W, Zhu C, Bozec A, Huang J, Chen Z. Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-α-mediated ERK1/2 and JAK-STAT1 pathways. Ann Rheum Dis 2022:annrheumdis-2022-222605. [PMID: 35760450 DOI: 10.1136/ard-2022-222605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Co DO, Kwon JM. Autoimmune Encephalitis: Distinguishing Features and Specific Therapies. Critical Care Clinics 2022;38:393-412. [DOI: 10.1016/j.ccc.2021.11.007] [Reference Citation Analysis]